Health and Medicine

FSI’s researchers assess health and medicine through the lenses of economics, nutrition and politics. They’re studying and influencing public health policies of local and national governments and the roles that corporations and nongovernmental organizations play in providing health care around the world. Scholars look at how governance affects citizens’ health, how children’s health care access affects the aging process and how to improve children’s health in Guatemala and rural China. They want to know what it will take for people to cook more safely and breathe more easily in developing countries.

FSI professors investigate how lifestyles affect health. What good does gardening do for older Americans? What are the benefits of eating organic food or growing genetically modified rice in China? They study cost-effectiveness by examining programs like those aimed at preventing the spread of tuberculosis in Russian prisons. Policies that impact obesity and undernutrition are examined; as are the public health implications of limiting salt in processed foods and the role of smoking among men who work in Chinese factories. FSI health research looks at sweeping domestic policies like the Affordable Care Act and the role of foreign aid in affecting the price of HIV drugs in Africa.

Paragraphs

Shorenstein APARC's annual report for the academic year 2023-24 is now available.

Learn about the research, publications, and events produced by the Center and its programs over the last academic year. Read the feature sections, which look at the historic meeting at Stanford between the leaders of Korea and Japan and the launch of the Center's new Taiwan Program; learn about the research our faculty and postdoctoral fellows engaged in, including a study on China's integration of urban-rural health insurance and the policy work done by the Stanford Next Asia Policy Lab (SNAPL); and catch up on the Center's policy work, education initiatives, publications, and policy outreach. Download your copy or read it online below.

All Publications button
1
Publication Type
Annual Reports
Publication Date
Authors
1
Asia Health Policy Postdoctoral Fellow, 2024-2025
Mai Nguyen.JPG Ph.D.

Mai Nguyen joined the Walter H. Shorenstein Asia-Pacific Research Center (APARC) as Asia Health Policy Postdoctoral Fellow for the 2024-2025 academic year. She holds a PhD in health services and health policy from Queensland University of Technology (QUT), Australia, and a Master of Science from Heller School for Social Policy and Management, Brandeis University.

Her doctoral research focused on how the expanding private healthcare sector can be managed more effectively to better supplement public health services to achieve universal health coverage in Vietnam. The study analyzed large and complex national health datasets from two consecutive Household Living Standard Surveys, clinical hospital data at national levels and in-depth interviews with key stakeholders of Vietnam's health system to investigate consumers' choice for private and public health care services in Vietnam. Her research findings have implications for policy change in terms of harnessing and regulating private health services in Vietnam and other Asia-Pacific countries, especially low and middle-income countries.

Dr. Nguyen has worked as a senior health specialist at Vietnam Ministry of Health. Her research interest stems from her professional experience in health policy and program management, including health policy and management, health services, private healthcare and health equity. Her works have been published in many Q1-international journals such as BMC Public Health, BMC Health Services Research, Human Resources for Health and International Journal of Health Policy and Management.

At APARC, Dr. Nguyen extended her research on the roles of private healthcare to supplement the public health sector to address the growing burden of chronic diseases and conditions in Vietnam.

Date Label
Authors
News Type
News
Date
Paragraphs

The Walter H. Shorenstein Asia-Pacific Research Center (APARC) is pleased to invite applications for a host of fellowships in contemporary Asia studies to begin in Autumn quarter 2025.

The Center offers postdoctoral fellowships that promote multidisciplinary research on Asia-focused health policy, contemporary Japan, and contemporary Asia broadly defined, postdoctoral fellowships and visiting scholar positions with the Stanford Next Asia Policy Lab, and a fellowship for experts on Southeast Asia. Learn more about each opportunity and its eligibility and specific application requirements:

Asia Health Policy Program Postdoctoral Fellowship

Hosted by the Asia Health Policy Program at APARC, the fellowship is awarded to one recent PhD undertaking original research on contemporary health or healthcare policy of high relevance to countries in the Asia-Pacific region, especially developing countries. Appointments are for one year beginning in Autumn quarter 2025. The application deadline is December 1, 2024.

Japan Program Postdoctoral Fellowship

Hosted by the Japan Program at APARC, the fellowship supports research on contemporary Japan in a broad range of disciplines including political science, economics, sociology, law, policy studies, and international relations. Appointments are for one year beginning in Autumn quarter 2025. The application deadline is December 1, 2024.  

Shorenstein Postdoctoral Fellowship on Contemporary Asia

APARC offers two postdoctoral fellowship positions to junior scholars for research and writing on contemporary Asia. The primary research areas focus on political, economic, or social change in the Asia-Pacific region (including Northeast, Southeast, and South Asia), or international relations and international political economy in the region. Appointments are for one year beginning in Autumn quarter 2025. The application deadline is December 1, 2024. 
 

Read More

2024 Incoming Fellows at Shorenstein APARC
News

APARC Names 2024 Incoming Fellows

The Center’s new cohort of nine scholars pursues research spanning diverse topics across contemporary Asia studies.
APARC Names 2024 Incoming Fellows
Hero Image
Stanford building with palm trees and architectural details on the foreground and text "Call for Applications: Fall 2025 Fellowships" and APARC logo.
All News button
1
Subtitle

The Center offers multiple fellowships for Asia researchers to begin in Autumn quarter 2025. These include postdoctoral fellowships on Asia-focused health policy, contemporary Japan, and the Asia-Pacific region, postdoctoral fellowships and visiting scholar positions with the Stanford Next Asia Policy Lab, a visiting scholar position on contemporary Taiwan, and fellowships for experts on Southeast Asia.

Date Label
-
Flyer for the talk "Procurement Institutions and Essential Drug Supply in Low- and Middle-Income Countries" with headshot of speaker  Lucy Xiaolu Wang.

Note: This talk is also offered as a virtual webinar on April 4 at 6 p.m.

International procurement institutions have played an important role in drug supply. This paper studies price, delivery, and procurement lead time of drug supply for major infectious diseases (antiretrovirals, antimalarials, antituberculosis, and antibiotics) in 106 developing countries from 2007-2017 across four procurement institution types. We find that pooled procurement institutions lower prices: pooling internationally is most effective for small buyers and more concentrated markets, and pooling within-country is most effective for large buyers and less concentrated markets. Pooling can reduce delays, but at the cost of longer anticipated procurement lead times. Finally, pooled procurement is more effective for older-generation drugs, compared to intellectual property licensing institutions that focus on newer, patented drugs. We corroborate the findings using multiple identification strategies, including an instrumental variable strategy, the Altonji-Elder-Taber-Oster method, and reduced-form demand estimation. Our results suggest that the optimal mixture of procurement institutions depends on the trade-off between costs and urgency of need, with pooled international procurement institutions particularly valuable when countries can plan well ahead of time.

Coauthor: Nahim Bin Zahur (Queen’s University).

Image
Lucy Xiaolu Wang 040424

Dr. Lucy Xiaolu Wang is a tenure-track Assistant Professor at University of Massachusetts Amherst, a Faculty Research Fellow at the Max Planck Institute for Innovation and Competition, Germany, and a Faculty Associate at the Canadian Centre for Health Economics. Her research focuses on the economics of innovation & digitization in health care markets (national and global), particularly in the biopharmaceutical and digital health industries. Dr. Wang earned her PhD in economics from Cornell University, her master’s degree in economics from Duke University, and her bachelor’s degree in applied economics (specialty: insurance) from Central University of Finance and Economics in Beijing, China. 

Karen Eggleston
Karen Eggleston, Director of the Stanford Asia Health Policy Program
Lucy Xiaolu Wang, University of Massachusetts Amherst; Max Planck Institute for Innovation and Competition; Canadian Centre for Health Economics
Seminars
-
Flyer for the talk "Procurement Institutions and Essential Drug Supply in Low- and Middle-Income Countries" with headshot of speaker  Lucy Xiaolu Wang.

Note: This talk is also offered as an in-person seminar on April 5 at 12 p.m.

International procurement institutions have played an important role in drug supply. This paper studies price, delivery, and procurement lead time of drug supply for major infectious diseases (antiretrovirals, antimalarials, antituberculosis, and antibiotics) in 106 developing countries from 2007-2017 across four procurement institution types. We find that pooled procurement institutions lower prices: pooling internationally is most effective for small buyers and more concentrated markets, and pooling within-country is most effective for large buyers and less concentrated markets. Pooling can reduce delays, but at the cost of longer anticipated procurement lead times. Finally, pooled procurement is more effective for older-generation drugs, compared to intellectual property licensing institutions that focus on newer, patented drugs. We corroborate the findings using multiple identification strategies, including an instrumental variable strategy, the Altonji-Elder-Taber-Oster method, and reduced-form demand estimation. Our results suggest that the optimal mixture of procurement institutions depends on the trade-off between costs and urgency of need, with pooled international procurement institutions particularly valuable when countries can plan well ahead of time.

Coauthor: Nahim Bin Zahur (Queen’s University).

Image
Lucy Xiaolu Wang 040424

Dr. Lucy Xiaolu Wang is a tenure-track Assistant Professor at University of Massachusetts Amherst, a Faculty Research Fellow at the Max Planck Institute for Innovation and Competition, Germany, and a Faculty Associate at the Canadian Centre for Health Economics. Her research focuses on the economics of innovation & digitization in health care markets (national and global), particularly in the biopharmaceutical and digital health industries. Dr. Wang earned her PhD in economics from Cornell University, her master’s degree in economics from Duke University, and her bachelor’s degree in applied economics (specialty: insurance) from Central University of Finance and Economics in Beijing, China. 

Karen Eggleston
Karen Eggleston, Director of the Stanford Asia Health Policy Program

Online via Zoom Webinar

Lucy Xiaolu Wang, University of Massachusetts Amherst; Max Planck Institute for Innovation and Competition; Canadian Centre for Health Economics
Seminars
-
(Machine) Learning About Sudden Cardiac Death

Co-sponsored by Peking University's Institute for Global Health and Development and the Asia Health Policy Program

Every year, hundreds of thousands of people suffer sudden cardiac death. What makes these deaths so tragic is that many of them are preventable, with an implanted cardioverter defibrillator (ICD) — if only we could know who was at high risk before they died. Using a massive new dataset of electrocardiograms (ECGs) linked to death certificates, we predict sudden cardiac death far better than current methods, both in a hold-out set of Swedish patients and in a completely independent dataset from Taiwan. We also show that high-risk patients — and only high-risk patients — who receive ICDs have significantly lower mortality. Finally, we create a generative model of the ECG waveform to tie what the model is ‘seeing’ back to underlying cardiac electrophysiology.

Image
Obermeyer Z - 20240221

Ziad Obermeyer's research uses machine learning to help doctors make better decisions and help researchers make new discoveries — by ‘seeing’ the world the way algorithms do. His work on algorithmic racial bias has impacted how many organizations build and use algorithms, and how lawmakers and regulators hold AI accountable. He is a co-founder of Nightingale Open Science and Dandelion Health, a Chan Zuckerberg Biohub Investigator, and a faculty research fellow at the National Bureau of Economic Research. He was named one of the 100 most influential people in AI by TIME magazine. Previously, he was an assistant professor at Harvard Medical School and continues to practice emergency medicine in underserved communities.

Jianan Yang, Assistant Professor of Economics, Institute for Global Health and Development, Peking University

Online via Zoom Webinar

Ziad Obermeyer, Associate Professor, Blue Cross of California Distinguished Professor, UC Berkeley
Seminars
Authors
News Type
News
Date
Paragraphs

Telemedicine has faced an uphill battle in South Korea and in fact, under the nation’s Medical Services Act, it is currently prohibited, a result of opposition from the medical community and other stakeholders. However, during the height of the COVID-19 pandemic, the South Korean government temporarily allowed for prescriptions and counseling by phone, which gave investigators the opportunity to examine patient preferences toward the service. 

It has been demonstrated that for consultations on chronic diseases—diabetes, hypertension, and heart disease—telemedicine is effectively equal to in-person visits, and moreover is convenient. Previous studies have looked at patient attitudes toward telemedicine but not many have used the COVID-19 pandemic as a backdrop. 

A new study, published in the Asia Pacific Journal of Public Health, helps to address this knowledge gap. The researchers focused on patients with the chronic diseases of diabetes and hypertension in South Korea and asked them about their preferences for telemedicine versus in-person care, including under different levels of recommended social distancing.

The co-authors of the study are Karen Eggleston, director of the Asia Health Policy Program at Shorenstein APARC; Annie Chang, ’21, MS ’22, currently an MD candidate at Icahn School of Medicine at Mount Sinai in New York City, who started the project as a Stanford student; Richard Liang, MD/PhD candidate at Stanford, and Daejung Kim of the Korea Institute for Health and Social Affairs.

The data was collected from a larger study on the impacts of the pandemic on the management of chronic disease in a number of Asian countries.

Chang notes that her research with Eggleston began after taking her course Health and Healthcare Systems in East Asia: “As a Korean American, I was naturally interested in learning more about South Korea and its healthcare system. I had the opportunity to work with Dr. Eggleston during the COVID-19 pandemic, when telemedicine usage surged globally.”

The study findings indicate that respondents did not have a strong preference for telemedicine services during the COVID-19 pandemic. This could be attributed to the prohibition of such services outside of the pandemic, to unfamiliarity with the technology, or to other factors.

However, the results show that attitudes toward telemedicine differed among demographic segments: younger patients, who tend to be more familiar with new technologies, had a higher preference for telemedicine, as did males (who are more likely to be employed, restricting their time for in-person visits), and those whose access to healthcare was more restricted.

This research carries significant policy implications concerning the advancement of telemedicine in South Korea and elsewhere. To make better use of telemedicine, policymakers should raise awareness of and familiarity with the services, especially among older populations who are less comfortable with new technologies. There is also a need to develop basic guidelines for telemedicine practices like reimbursement and data security to encourage the adoption of telemedicine as a viable alternative to in-person consultations. 

Read More

Cover of book "Who Shall Live" in front of Encina Hall
News

An Update to a Classic Work of Health Economics

Asia Health Policy Program Director Karen Eggleston has coauthored the new third edition of Victor Fuch's 'Who Shall Live: Health, Economics, and Social Choice,' an authoritative book considering the great health challenges of our time.
An Update to a Classic Work of Health Economics
Asia Health Policy Postdoctoral Fellow, Jianan Yang
Q&As

Toward Healthier Outcomes: Examining Health Policies and Their Effects on Patient Behavior

In this interview, Asia Health Policy Postdoctoral Fellow Jianan Yang discusses her research into the economics of patient behavior and the pharmaceutical industry in developing countries.
Toward Healthier Outcomes: Examining Health Policies and Their Effects on Patient Behavior
Pouring multi-colored capsule pills from plastic drug bottle. Antibiotic drug overuse concept.
News

How Social-Health Nudges Can Help Combat Antibiotic Resistance

A new study by researchers including APARC's Asia Health Policy Postdoctoral Fellow Dr. Jianan Yang reveals that text messages providing information on the harmful social impacts of antibiotic resistance help reduce antibiotics purchase, identifying a cost-effective means of addressing the risks of antibiotics misuse and overuse.
How Social-Health Nudges Can Help Combat Antibiotic Resistance
Hero Image
A man holding a pill case consults on his computer with a female doctor. Maki Nakamura/Getty Images
All News button
1
Subtitle

A new study, co-authored by Asia Health Policy Director Karen Eggleston, investigated preferences for telemedicine services for chronic disease care in South Korea during the COVID-19 pandemic and found that preferences differed according to patient demographics.

Authors
News Type
News
Date
Paragraphs

This announcement was updated on October 6, 2023, to reflect the addition of two new fellowship offerings focused on contemporary Taiwan.


The Walter H. Shorenstein Asia-Pacific Research Center (APARC) is pleased to invite applications for a suite of fellowships in contemporary Asia studies to begin fall quarter 2024.

The Center offers postdoctoral fellowships that promote multidisciplinary research on Asia-focused health policy; contemporary Japan; contemporary Asia broadly defined; postdoctoral fellowships and visiting scholar positions as part of the new Stanford Next Asia Policy Lab; and a fellowship for experts on Southeast Asia. Learn more about each opportunity and its eligibility and specific application requirements:

Asia Health Policy Postdoctoral Fellowship

Hosted by the Asia Health Policy Program at APARC, the fellowship is awarded annually to one recent PhD undertaking original research on contemporary health or healthcare policy of high relevance to countries in the Asia-Pacific region, especially developing countries. Appointments are for one year beginning in fall quarter 2024. The application deadline is December 1, 2023.

Postdoctoral Fellowship on Contemporary Japan

Hosted by the Japan Program at APARC, the fellowship supports research on contemporary Japan in a broad range of disciplines including political science, economics, sociology, law, policy studies, and international relations. Appointments are for one year beginning in fall quarter 2024. The application deadline is December 1, 2023.  
 

Shorenstein Postdoctoral Fellowship on Contemporary Asia

APARC offers two postdoctoral fellowship positions to junior scholars for research and writing on contemporary Asia. The primary research areas focus on political, economic, or social change in the Asia-Pacific region (including Northeast, Southeast, and South Asia), or international relations and international political economy in the region. Appointments are for one year beginning in fall quarter 2024. The application deadline is December 1, 2023.  
 

Read More

Hero Image
Stanford architectural columns with text "Call for Applications: Fall 2024 Fellowships" and APARC logo.
All News button
1
Subtitle

The Center offers a suite of fellowships for Asia researchers to begin in fall quarter 2024. These include postdoctoral fellowships on Asia-focused health policy, contemporary Japan, and the Asia-Pacific region, postdoctoral fellowships and visiting scholar positions with the Stanford Next Asia Policy Lab, and fellowships for experts on Southeast Asia.

Authors
News Type
Q&As
Date
Paragraphs

While access to essential health services has expanded in the 21st century for a significant segment of the world’s population, progress is uneven. Low- and middle-income economies continue to grapple with healthcare access challenges due to factors such as shortage of trained health workers, equipment and medicines, poverty, insufficient health insurance, and information gaps. That’s why Jianan Yang, APARC's 2022-23 Asia Health Policy Postdoctoral Fellow, studies the characteristics and potential inefficiencies of the pharmaceutical market in developing countries. Yang's research, situated at the intersection of development and health economics, focuses on understanding drivers of suboptimal healthcare-seeking behaviors in developing nations and exploring how price and non-price mechanisms can drive improvement.

APARC’s Asia Health Policy Program awards the Asia Health Policy postdoctoral fellowship annually to support a recent PhD undertaking original research on contemporary health or healthcare policy of high relevance to countries in the Asia-Pacific region, especially developing countries.

Yang earned her Ph.D. in Economics at the University of California San Diego. In Yang’s dissertation, she studied how drug price reductions in China affected drug utilization by patients with chronic conditions. The study documented a significant increase in utilization and a meaningful reduction in underuse among the uninsured, suggesting there are higher price elasticities in developing countries. The findings indicate that reducing drug prices, which squeeze out the price markups imposed by pharmaceutical companies due to their market power, can lead to substantial  welfare benefits.

We caught up with Yang to hear more about her fellowship experience this academic year and what’s next. The conversation has been slightly edited for length and clarity.

First off, can you briefly describe your research?

My research aims to improve population health in developing countries by focusing on two main areas. Firstly, I study patient behavior and how it can be influenced by public policies and social events. For example, I investigate whether providing patients with information on antibiotics resistance can reduce overuse and examine the impact of price reductions on medication utilization and adherence for chronic conditions. While my previous research primarily focused on China, I am currently engaged in an ongoing project in the Philippines. This project assesses the effects of the 2017 Dengvaxia controversy on childhood vaccination and maternal healthcare utilization.

Secondly, I explore the pharmaceutical industry in developing countries, which plays a critical role in supplying novel drugs and ensuring the quality of existing ones. I assess the effects of public policies on drug quality and on the quantity and quality of pharmaceutical innovation.

Through my work, I strive to contribute valuable insights that can inform evidence-based policies for improving healthcare outcomes in developing countries.

How did you come to be interested in your current research?

What drew me to this topic was the profound significance of health in human development. Health is not only essential for productive human capital but also serves as a fundamental aspect of our overall well-being. Personally, like many others, I have experienced illness firsthand and witnessed the challenges that loved ones faced during periods of illness. These personal experiences have deepened my understanding of the critical role that good health plays in our lives.

Furthermore, the field of healthcare presents numerous challenges and uncertainties. These challenges are even more prominent in developing countries. Inspired by these complexities, I chose to focus on my familiar context of China and approached the issue from an economics perspective to explore ways of enhancing population health.

Congratulations on your recent publication in the Journal of Development Economics! How did you develop this study?

Thank you! The journey of developing this study began in the summer of 2018, when I returned to China during a break in my graduate school studies. At that time, having completed my coursework, I was eager to apply the research methodologies I had learned and explore meaningful projects. It was fortuitous that I connected with my coauthors, who introduced me to the possibility of conducting an experiment at a primary care facility in Beijing, focusing on the pressing issue of antibiotics resistance.

Antibiotics resistance is a significant concern, particularly in developing countries like China, where the misuse and overuse of antibiotics contribute to its exacerbation. In this project, we investigated whether providing individuals with information about the threat of antibiotics resistance to public health could lead to changes in their antibiotics purchasing behavior.

To our surprise, we discovered that a simple message conveying the potential social impact of antibiotics resistance had a substantial effect. This finding highlighted the potential of informational interventions in shaping behavior and addressing critical public health challenges. This study aimed to contribute to the broader understanding of behavioral responses to health-related information and provide insights into effective strategies for tackling antibiotics resistance.

How has your time at APARC as the Asia Health Policy Postdoctoral Fellow aided your research?

The Asia Health Policy Postdoctoral Fellowship has been immensely beneficial to my research in several ways. Firstly, it provided me with invaluable flexibility to conduct my own research. This freedom allowed me to dedicate time and effort to revising my work, ultimately resulting in the successful publication of the paper we just mentioned.

Additionally, the funding support associated with the fellowship enabled me to attend numerous conferences relevant to my research area. These conferences served as excellent platforms for presenting my work and establishing valuable connections with fellow researchers in the field. These connections have been instrumental in expanding my professional network and fostering collaborations.

Moreover, as part of my responsibilities, I had the privilege of organizing the Peking University – AHPP joint webinar series this year. This opportunity not only sharpened my skills in organizing and moderating webinars but also provided a unique chance to engage with senior scholars in the field, whose work I have long admired. The interactions and insights gained from these scholars have been tremendously enriching for my research journey.

Overall, my time as an Asia Health Policy Postdoctoral Fellow at APARC has provided me with the necessary resources, flexibility, and networking opportunities to advance my research, strengthen my skills, and cultivate meaningful connections within the academic community.

What other aspects of your time at APARC have you benefited from?

During my time at APARC, I have benefited from various aspects beyond the Asia Health Policy Postdoctoral Fellowship itself. One notable advantage has been the vibrant and diverse Stanford community focused on health-related topics. This academic environment has allowed me to engage with health economists from the Economics Department and collaborate with public health scholars from the Health Policy Department. This interdisciplinary exposure has broadened my perspectives and enriched my understanding of the complex intersection between health and policy.

Additionally, I have had the opportunity to establish connections with fellow postdoctoral fellows and early-career scholars who share similar research interests. Through small group seminars and research presentations, we have formed a supportive network, providing valuable feedback and insights to one another. These interactions have fostered an environment of intellectual exchange and growth, further enhancing the quality and impact of our research endeavors.

Are there any people at APARC that you particularly benefited from working with?

Working at APARC has provided me with valuable opportunities to collaborate and learn from various scholars. One individual with whom I have particularly enjoyed collaborating with is Global Affiliate Visiting Fellow Jitukrushna Swain, of Reliance Life Sciences in India. Despite our different academic backgrounds, we share a common interest in the field. Through auditing classes together and engaging in insightful conversations, Jitu has provided invaluable insights into the innovation incentives within the pharmaceutical industry and other intricate aspects of the field. This collaboration has greatly enhanced my understanding of the industry and enriched my research.

Furthermore, being a part of APARC has allowed me to interact with scholars from diverse fields within the social sciences. Communicating my own research to them has provided valuable perspectives and allowed for interdisciplinary exchanges that have broadened my understanding of the social, economic, and political implications of my work.

What is on the horizon for you? What's next?

I am excited to share that my next step will be joining the Peking University Institute of Global Health and Development as an assistant professor this fall. This new opportunity will allow me to continue my research and contribute to the field of global health and development from an academic position. I am looking forward to further exploring critical issues, conducting impactful research, and collaborating with colleagues at Peking University and beyond. I am eager to embark on this new chapter in my career, and I am excited about the possibilities and contributions that lie ahead.

Do you have any advice for students interested in your field?

For students interested in pursuing a career in this area, firstly, I would encourage you to immerse yourself in the field by gaining practical experience and exposure to the realities of the issues you wish to address. Direct engagement will provide valuable insights and help you better understand the nuances and complexities of the field.

Secondly, invest time in building a solid foundation of knowledge by delving deep into the existing literature. Familiarize yourself with key theories, methodologies, and empirical findings in your area of interest. This will equip you with a strong understanding of the field and enable you to identify gaps in knowledge that can serve as potential research avenues.

Lastly, be bold and passionate in your pursuit of questions and topics that you genuinely believe are valuable for enhancing human well-being. The field you are interested in is filled with open questions and challenges waiting to be addressed. Trust your instincts and follow your interests. Undertake research that aligns with your values and has the potential to make a meaningful impact.

Stay curious, collaborate with peers and experts in the field, and be open to new perspectives and approaches. By actively engaging in the field, expanding your knowledge, and pursuing questions that resonate with you, you can contribute to meaningful advancements in your chosen area and make a positive difference in the lives of individuals and communities. 
 

Read More

Pouring multi-colored capsule pills from plastic drug bottle. Antibiotic drug overuse concept.
News

How Social-Health Nudges Can Help Combat Antibiotic Resistance

A new study by researchers including APARC's Asia Health Policy Postdoctoral Fellow Dr. Jianan Yang reveals that text messages providing information on the harmful social impacts of antibiotic resistance help reduce antibiotics purchase, identifying a cost-effective means of addressing the risks of antibiotics misuse and overuse.
How Social-Health Nudges Can Help Combat Antibiotic Resistance
Hero Image
Asia Health Policy Postdoctoral Fellow, Jianan Yang
Asia Health Policy Postdoctoral Fellow, Jianan Yang
All News button
1
Subtitle

In this interview, Asia Health Policy Postdoctoral Fellow Jianan Yang discusses her research into the economics of patient behavior and the pharmaceutical industry in developing countries.

-
Flyer for "Information Barriers to Social Health Protection in Pakistan"

Co-sponsored by Peking University Institute for Global Health and Development, and the Asia Health Policy Program

Pakistan followed the example of many large Asian countries and started introducing publicly financed health insurance under the so-called "Sehat Sahulat Program" (SSP) from 2015 onwards. The SSP initially covered hospitalization expenses for poor households in selected districts and by now covers millions of households all over Pakistan. This talk explains the recent reforms, focusing on information barriers to utilizing the SSP. In particular awareness about coverage seems to be a key issue, making the system not easy to navigate for poor households. A first study shows that education plays an important role for successfully utilizing health care under the scheme in this context. Information and awareness about financial protection, however, is only one element of health care decisions. Even if beneficiaries know which household members are covered under which condition in which facility, they might still be unsure about where treatment is most appropriate given their medical condition. A second study thus provides theoretical and empirical evidence on how incomplete financial and medical information jointly affect health provider choices, and how this might explain limited health service utilization under the SSP.

Image
Andreas Landmann

Andreas Landmann is a Full Professor of Development Economics at the Friedrich-Alexander University (FAU) Erlangen-Nürnberg where he uses applied econometrics and behavioral research in the area of development economics. A lot of his work investigates insurance in low-income countries, with a special focus on health. In particular, he analyzes different impact evaluations on health insurance provision in Pakistan. Additionally, he is interested in decisions under risk and uncertainty, as well as prosocial preferences. He conducted several large-scale impact evaluations, randomized control trials, and behavioral experiments in the Philippines, Germany, Vietnam, China, and Pakistan, all of them including primary data collection. Prior to joining the FAU, he held research positions at the University of Göttingen, the Paris School of Economics, and the University of Mannheim, from where he also holds a PhD.

Jianan Yang

Online via Zoom Webinar

Andreas Landmann Professor of Development Economics, the Friedrich-Alexander University (FAU) Erlangen-Nürnberg
Seminars
Subscribe to Health and Medicine